Squamous Lung Cancer Part 5, Q and A Session by Dr. David Spigel
Article
Dr. David Spigel, Sarah Cannon Cancer Center, answers audience questions about squamous lung cancer.
[powerpress]
Squamous Lung Cancer, Part 4: Immunotherapy by Dr. David Spigel
Article
Dr. David Spigel, Sarah Cannon Cancer Center, describes current research in immunotherapy as treatment for squamous lung cancer.
[powerpress]
Squamous Lung Cancer, Part 3: Treatment by Dr. David Spigel
Article
Dr. David Spigel, Sarah Cannon Cancer Center, outlines treatment options for squamous lung cancer.
[powerpress]
Squamous Lung Cancer, Part 3: Treatment Audio Podcast
Squamous Lung Cancer, Part 2: Genomic Testing by Dr. David Spigel
Article
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the importance of genomic testing in squamous lung cancer.
[powerpress]
Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup by Dr. David Spigel
Article
Dr. David Spigel, Sarah Cannon Cancer Center, describes the diagnosis, presentation and workup of squamous lung cancer.
[powerpress]
Dr. David Spigel on "Which molecular marker tests do you seek?"
Article
Dr. David Spigel, Sarah Cannon Cancer Center, describes which molecular markers he seeks for NSCLC patients.
[powerpress]
Dr. David Spigel: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Article
Dr. David Spigel gives his view on more widespread availability of new mutation tests, provides his perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for other lung cancer subtypes.
[powerpress]
Can we harness our immune system to fight NSCLC?
Article
Drs. Mary Pinder, Nate Pennell, and Jack West discuss promising work on immune checkpoint inhibitors such as MPPL-3280A, an anti-PDL1 immune-based therapy, and anti-PD1 therapy nivolumab, in advanced NSCLC.
[powerpress]
Dr. David Spigel: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?
Article
Dr. David Spigel, Sarah Cannon Cancer Center, gives his view on more widespread availability of new mutation tests.
[powerpress]
Dr. David Spigel: How Do I Discuss the Side Effects of Targeted Therapies, as Compared with Chemotherapy?
Article
Dr. David Spigel, Sarah Cannon Cancer Center, discusses his perspective on side effects of targeted therapies as compared with standard chemotherapy for patients with lung cancer.
[powerpress]